Brassica-Derived Plant Bioactives as Modulators of Chemopreventive and Inflammatory Signaling Pathways.

A high consumption of vegetables belonging to the family has been related to a lower incidence of chronic diseases including different kinds of cancer. These beneficial effects of, e.g.

Myrosinase-treated glucoerucin is a potent inducer of the Nrf2 target gene heme oxygenase 1--studies in cultured HT-29 cells and mice.

In this study, the effect of myrosinase-treated glucoerucin (GER+MYR), which releases the isothiocyanate (ITC) erucin, on heme oxygenase 1 (HO-1) gene expression and Nrf2 signaling was investigated in vitro in cultured cells and in vivo in mice. Treatment of HT-29 cells with GER+MYR resulted in a significant increase in the mRNA and protein levels of nuclear Nrf2 and HO-1. GER+MYR was more potent at enhancing the nuclear Nrf2 levels than were the following myrosinase-treated glucosinolates: sinigrin, glucoraphanin and gluconasturtiin, which are the precursors of allyl-ITC, R-sulforaphane and 2-phenylethyl ITC, respectively.

¹³C NMR spectroscopy as a tool for the in situ characterisation of iron-supplementing preparations.

(13)C NMR spectroscopy provides insight into the chemistry of carbohydrate-based ferric preparations. Specifically, it reveals whether oxygen atoms of the carbohydrate are directly bonded to the preparations' ferric centres or whether more distant interactions are present. After having validated the method by investigating the ferric solutions of low-molecular complexes as well as polynuclear ferric samples, it is demonstrated that common constituents of medically used ferric preparations such as sucrose and other glucose-based saccharides do not support ferric carbohydrate chelates.

DSS-induced acute colitis in C57BL/6 mice is mitigated by sulforaphane pre-treatment.

The Brassica-derived isothiocyanate sulforaphane (SFN) is known to induce factor erythroid 2-related factor 2 (Nrf2), a transcription factor centrally involved in chemoprevention. Furthermore, SFN exhibits anti-inflammatory properties in vitro and in vivo. However, little is known regarding the anti-inflammatory properties of SFN in severe inflammatory phenotypes.

The warning glove - development and evaluation of a multimodal action-specific warning prototype.

This paper has two objectives: first, to introduce the concept of multimodal action-specific warnings and its prototypic realization in the form of a warning glove and second, to present the main findings of a user study that was conducted to test the warning glove against a conventional warning system. Regarding the first goal, the combination of multimodality and action-specificity was implemented by attaching electronic actuators on a right-handed glove for transmitting visual, auditory and tactile feedback. For the second objective, a user study was conducted to test the hypothesis that the warning glove is capable of obtaining faster responses and to determine the perceptions of the users regarding the appropriateness of the warning glove.

How can multimodality be used to design usable interfaces in IPS2 for older employees?

Main objective of the recently started collaborative research project SFB/TR29 B4 is to provide cross-generational assistance to human operators working in industrial product-service systems (IPS(2)). By combining the ideas of action-specificity and multimodality a more immediate and purposeful reaction towards warnings is assumed. For this purpose, an action-specific warning system in form of a glove has been developed.

Fab antibodies capable of blocking T cells by competitive binding have the identical specificity but a higher affinity to the MHC-peptide-complex than the T cell receptor.

In transplant rejection, graft versus host or autoimmune diseases T cells are mediating the pathophysiological processes. Compared to unspecific pharmacological immune suppression specific inhibition of those T cells, that are involved in the disease, would be an alternative and attractive approach. T cells are activated after their T cell receptor (TCR) recognizes an antigenic peptide displayed by the Major Histocompatibility Complex (MHC).

Differential presentation of tumor antigen-derived epitopes by MHC-class I and antigen-positive tumor cells.

SSX2 is a member of the family of cancer/testis antigens. The SSX2 derived peptide SSX2(103-111) has been shown to be presented to cytotoxic T-lymphocytes (CTL) by Major-Histocompatibility (MHC) Class-I complexes after endogenous processing, more precisely by the allele HLA-A*0201. The HLA-A*0201- and SSX2-positive melanoma cell line SK-Mel-37 but not Me275 had been shown to elicit reactivity in SSX2(103-111) specific cytotoxic T-lymphocytes.

MHC-peptide-specific antibodies reveal inefficient presentation of an HLA-A*0201-restricted, Melan-A-derived peptide after active intracellular processing.

MHC-peptide-specific Fab antibodies binding to HLA-A*0201 complexes presenting the wild-type EAAGIGILTV (EAA) or analogue Melan-A 10-mer ELAGIGILTV (ELA) peptide were generated to study efficacy of peptide processing and presentation. None of the selected Fab antibodies detected the naturally processed EAA/HLA-A*0201 complex on melanoma tumor cells, confirming the known low peptide number on the cell surface. To study the effect of peptide presentation and processing in more detail, genes coding for the A27L-mutated Melan-A protein or the processed ELA peptide were introduced into HLA-A*0201(+) B cells by infection with the respective recombinant vaccinia virus construct producing equimolar amounts of GFP-ubiquitin directly linked to the fragment of interest.

Cryptococcal thyroiditis and hyperthyroidism.

We report a case of cryptococcal thyroiditis presenting with hyperthyroidism that evolved through a transient euthyroid phase to hypothyroidism and finally recovered to normal function. This four-phase clinical presentation is similar to that of subacute thyroiditis, and it is unusual in the setting of infectious nonviral thyroiditis. Cryptococcal thyroiditis is rare; only three cases have been reported.